nodes	percent_of_prediction	percent_of_DWPC	metapath
Ergonovine—ABCB1—Vismodegib—skin cancer	0.189	0.21	CbGbCtD
Ergonovine—CYP3A4—Temozolomide—skin cancer	0.164	0.182	CbGbCtD
Ergonovine—CYP3A4—Imiquimod—skin cancer	0.164	0.182	CbGbCtD
Ergonovine—CYP3A4—Vismodegib—skin cancer	0.113	0.126	CbGbCtD
Ergonovine—ABCB1—Dactinomycin—skin cancer	0.0994	0.11	CbGbCtD
Ergonovine—CYP3A4—Vemurafenib—skin cancer	0.0897	0.0995	CbGbCtD
Ergonovine—ABCB1—Docetaxel—skin cancer	0.0513	0.057	CbGbCtD
Ergonovine—CYP3A4—Docetaxel—skin cancer	0.0308	0.0341	CbGbCtD
Ergonovine—Arteriospasm coronary—Fluorouracil—skin cancer	0.0134	0.136	CcSEcCtD
Ergonovine—Pulmonary oedema—Imiquimod—skin cancer	0.00313	0.0317	CcSEcCtD
Ergonovine—Muscle spasms—Vismodegib—skin cancer	0.00281	0.0284	CcSEcCtD
Ergonovine—Nasal congestion—Imiquimod—skin cancer	0.0028	0.0284	CcSEcCtD
Ergonovine—Gastrointestinal pain—Vismodegib—skin cancer	0.00195	0.0197	CcSEcCtD
Ergonovine—Acute coronary syndrome—Imiquimod—skin cancer	0.00194	0.0196	CcSEcCtD
Ergonovine—Myocardial infarction—Imiquimod—skin cancer	0.00193	0.0195	CcSEcCtD
Ergonovine—Abdominal pain—Vismodegib—skin cancer	0.00188	0.0191	CcSEcCtD
Ergonovine—Thrombophlebitis—Temozolomide—skin cancer	0.00177	0.0179	CcSEcCtD
Ergonovine—Nasal congestion—Temozolomide—skin cancer	0.00168	0.017	CcSEcCtD
Ergonovine—Tinnitus—Imiquimod—skin cancer	0.00165	0.0167	CcSEcCtD
Ergonovine—Diarrhoea—Vismodegib—skin cancer	0.00163	0.0165	CcSEcCtD
Ergonovine—Thrombophlebitis—Fluorouracil—skin cancer	0.00163	0.0165	CcSEcCtD
Ergonovine—Vomiting—Vismodegib—skin cancer	0.00151	0.0153	CcSEcCtD
Ergonovine—Drug interaction—Docetaxel—skin cancer	0.00151	0.0153	CcSEcCtD
Ergonovine—Nausea—Vismodegib—skin cancer	0.00141	0.0143	CcSEcCtD
Ergonovine—Acute coronary syndrome—Bleomycin—skin cancer	0.00138	0.014	CcSEcCtD
Ergonovine—Hypotension—Vemurafenib—skin cancer	0.00138	0.0139	CcSEcCtD
Ergonovine—Myocardial infarction—Bleomycin—skin cancer	0.00137	0.0139	CcSEcCtD
Ergonovine—Palpitations—Imiquimod—skin cancer	0.00136	0.0138	CcSEcCtD
Ergonovine—Haematuria—Bleomycin—skin cancer	0.00133	0.0135	CcSEcCtD
Ergonovine—Hypertension—Imiquimod—skin cancer	0.00133	0.0134	CcSEcCtD
Ergonovine—Chest pain—Imiquimod—skin cancer	0.00131	0.0133	CcSEcCtD
Ergonovine—Pulmonary oedema—Docetaxel—skin cancer	0.00125	0.0126	CcSEcCtD
Ergonovine—Shock—Imiquimod—skin cancer	0.00123	0.0125	CcSEcCtD
Ergonovine—Hyperhidrosis—Imiquimod—skin cancer	0.00121	0.0123	CcSEcCtD
Ergonovine—Thrombophlebitis—Docetaxel—skin cancer	0.00118	0.0119	CcSEcCtD
Ergonovine—Dyspnoea—Imiquimod—skin cancer	0.00112	0.0113	CcSEcCtD
Ergonovine—Acute coronary syndrome—Fluorouracil—skin cancer	0.00107	0.0108	CcSEcCtD
Ergonovine—Myocardial infarction—Fluorouracil—skin cancer	0.00107	0.0108	CcSEcCtD
Ergonovine—Hallucination—Temozolomide—skin cancer	0.00105	0.0107	CcSEcCtD
Ergonovine—Gastrointestinal pain—Imiquimod—skin cancer	0.00103	0.0104	CcSEcCtD
Ergonovine—Diarrhoea—Vemurafenib—skin cancer	0.00101	0.0102	CcSEcCtD
Ergonovine—Abdominal pain—Imiquimod—skin cancer	0.000992	0.01	CcSEcCtD
Ergonovine—Tinnitus—Temozolomide—skin cancer	0.000987	0.00999	CcSEcCtD
Ergonovine—Dizziness—Vemurafenib—skin cancer	0.000973	0.00985	CcSEcCtD
Ergonovine—Vomiting—Vemurafenib—skin cancer	0.000936	0.00947	CcSEcCtD
Ergonovine—Chest pain—Bleomycin—skin cancer	0.00093	0.00942	CcSEcCtD
Ergonovine—Headache—Vemurafenib—skin cancer	0.000922	0.00933	CcSEcCtD
Ergonovine—Nausea—Vemurafenib—skin cancer	0.000874	0.00885	CcSEcCtD
Ergonovine—Diarrhoea—Imiquimod—skin cancer	0.000859	0.00869	CcSEcCtD
Ergonovine—Hypotension—Bleomycin—skin cancer	0.000833	0.00844	CcSEcCtD
Ergonovine—Dizziness—Imiquimod—skin cancer	0.00083	0.0084	CcSEcCtD
Ergonovine—Vertigo—Temozolomide—skin cancer	0.000828	0.00838	CcSEcCtD
Ergonovine—Palpitations—Temozolomide—skin cancer	0.000814	0.00825	CcSEcCtD
Ergonovine—Vomiting—Imiquimod—skin cancer	0.000798	0.00808	CcSEcCtD
Ergonovine—Hypertension—Temozolomide—skin cancer	0.000796	0.00806	CcSEcCtD
Ergonovine—Dyspnoea—Bleomycin—skin cancer	0.000795	0.00805	CcSEcCtD
Ergonovine—Headache—Imiquimod—skin cancer	0.000786	0.00796	CcSEcCtD
Ergonovine—Acute coronary syndrome—Docetaxel—skin cancer	0.000773	0.00783	CcSEcCtD
Ergonovine—Myocardial infarction—Docetaxel—skin cancer	0.000769	0.00778	CcSEcCtD
Ergonovine—Nausea—Imiquimod—skin cancer	0.000746	0.00755	CcSEcCtD
Ergonovine—Hyperhidrosis—Temozolomide—skin cancer	0.000727	0.00736	CcSEcCtD
Ergonovine—Chest pain—Fluorouracil—skin cancer	0.000723	0.00732	CcSEcCtD
Ergonovine—Gastrointestinal pain—Dactinomycin—skin cancer	0.00068	0.00688	CcSEcCtD
Ergonovine—Dyspnoea—Temozolomide—skin cancer	0.000671	0.00679	CcSEcCtD
Ergonovine—Abdominal pain—Dactinomycin—skin cancer	0.000657	0.00666	CcSEcCtD
Ergonovine—Hypotension—Fluorouracil—skin cancer	0.000648	0.00656	CcSEcCtD
Ergonovine—Dyspnoea—Fluorouracil—skin cancer	0.000618	0.00625	CcSEcCtD
Ergonovine—Gastrointestinal pain—Temozolomide—skin cancer	0.000615	0.00623	CcSEcCtD
Ergonovine—Abdominal pain—Temozolomide—skin cancer	0.000595	0.00602	CcSEcCtD
Ergonovine—Muscle spasms—Docetaxel—skin cancer	0.000589	0.00597	CcSEcCtD
Ergonovine—Diarrhoea—Dactinomycin—skin cancer	0.000569	0.00576	CcSEcCtD
Ergonovine—Vomiting—Bleomycin—skin cancer	0.000567	0.00574	CcSEcCtD
Ergonovine—Palpitations—Docetaxel—skin cancer	0.000542	0.00548	CcSEcCtD
Ergonovine—Nausea—Bleomycin—skin cancer	0.00053	0.00536	CcSEcCtD
Ergonovine—Hypertension—Docetaxel—skin cancer	0.000529	0.00536	CcSEcCtD
Ergonovine—Vomiting—Dactinomycin—skin cancer	0.000529	0.00535	CcSEcCtD
Ergonovine—Chest pain—Docetaxel—skin cancer	0.000522	0.00528	CcSEcCtD
Ergonovine—Diarrhoea—Temozolomide—skin cancer	0.000515	0.00521	CcSEcCtD
Ergonovine—Dizziness—Temozolomide—skin cancer	0.000497	0.00504	CcSEcCtD
Ergonovine—Nausea—Dactinomycin—skin cancer	0.000494	0.005	CcSEcCtD
Ergonovine—Shock—Docetaxel—skin cancer	0.000492	0.00498	CcSEcCtD
Ergonovine—Vomiting—Temozolomide—skin cancer	0.000478	0.00484	CcSEcCtD
Ergonovine—Diarrhoea—Fluorouracil—skin cancer	0.000474	0.0048	CcSEcCtD
Ergonovine—Headache—Temozolomide—skin cancer	0.000471	0.00477	CcSEcCtD
Ergonovine—Hypotension—Docetaxel—skin cancer	0.000467	0.00473	CcSEcCtD
Ergonovine—Dizziness—Fluorouracil—skin cancer	0.000458	0.00464	CcSEcCtD
Ergonovine—Nausea—Temozolomide—skin cancer	0.000447	0.00452	CcSEcCtD
Ergonovine—Dyspnoea—Docetaxel—skin cancer	0.000446	0.00451	CcSEcCtD
Ergonovine—Vomiting—Fluorouracil—skin cancer	0.000441	0.00446	CcSEcCtD
Ergonovine—Headache—Fluorouracil—skin cancer	0.000434	0.0044	CcSEcCtD
Ergonovine—Nausea—Fluorouracil—skin cancer	0.000412	0.00417	CcSEcCtD
Ergonovine—Gastrointestinal pain—Docetaxel—skin cancer	0.000409	0.00414	CcSEcCtD
Ergonovine—Abdominal pain—Docetaxel—skin cancer	0.000395	0.004	CcSEcCtD
Ergonovine—Diarrhoea—Docetaxel—skin cancer	0.000342	0.00346	CcSEcCtD
Ergonovine—Dizziness—Docetaxel—skin cancer	0.000331	0.00335	CcSEcCtD
Ergonovine—Vomiting—Docetaxel—skin cancer	0.000318	0.00322	CcSEcCtD
Ergonovine—Headache—Docetaxel—skin cancer	0.000313	0.00317	CcSEcCtD
Ergonovine—Nausea—Docetaxel—skin cancer	0.000297	0.00301	CcSEcCtD
